Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of MenABCWY versus active meningococcal vaccines in healthy participants aged 10 to under 26 years
2019-004313-13Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Meningococcal ABCYW vaccine in meningococcal disease (2 arms), sponsored by Pfizer. Started Jun 2020; status: completed.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2019-004313-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004313-13.